FDA Approved: ESCITALOPRAM — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved the supplemental application for escitalopram oxalate by Aurobindo Pharma Limited, enabling continued generic production and distribution.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder
• Major Depressive Disorder

Drugs mentioned

• Escitalopram (escitalopram)

Snippet

SUPPL AP for ESCITALOPRAM (ESCITALOPRAM OXALATE)